SCHEMBL13067941

SCHEMBL13067941

CN(C)C1=CCC(/C=C/C(=O)c2ccc(O)cc2)C=C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
TLR9 Q9NR96 1/20 0.44
MAPT P10636 7/20 0.40
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 4/20 0.40
F3 P13726 3/20 0.39
MAOB P27338 3/20 0.38
RAB9A P51151 3/20 0.38
MAOA P21397 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
POLB P06746 1/20 0.38
BCHE P06276 2/20 0.37
CAPN1 P07384 1/20 0.36
MEN1 O00255 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALDH2 P05091 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1076588 0.72 MAPT (0.41) MAPTALDH1A1KMT2AF3MAOB
SCHEMBL8421989 0.71 MAOB (0.43) MAPTALDH1A1KMT2AF3MAOB
SCHEMBL2024880 0.70 CAPN1 (0.44) MAPTALDH1A1KMT2AF3MAOB
SCHEMBL30254953 0.68 MAPT (0.42) MAPTALDH1A1KMT2AMAOBRAB9A
SCHEMBL2023110 0.66 CYP3A4 (0.47) MAPTALDH1A1KMT2AMAOBMAOA
SCHEMBL1186588 0.65 MAPT (0.70) CRHBPCRHR2TLR9MAPTALDH1A1
SCHEMBL1186589 0.65 MAPT (0.70) CRHBPCRHR2TLR9MAPTALDH1A1
Phenol SCHEMBL28311351 0.65 KMT2A (0.44) MAPTALDH1A1KMT2AF3MAOB
SCHEMBL4656458 0.64 MEN1 (0.47) MAPTALDH1A1KMT2AMEN1TDP1
SCHEMBL6906881 0.64 GUSB (0.47) MAPTALDH1A1KMT2AMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100278733-A1 COMPOSITION FOR DIAGNOSIS OF AMYLOID-RELATED DISEASE NAGASAKI UNIVERSITY (JP) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100278733-A1 COMPOSITION FOR DIAGNOSIS OF AMYLOID-RELATED DISEASE APP, FABP7, APBA1 CRHBP 604/4885CRHR2 3923/4885TLR9 4850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.